Summary In the family reported here, a mother and both of her children developed a Wilms tumour, and all three tumours were of the relatively rare monomorphous epithelial histopathological subtype. Using restriction fragment length polymorphism analysis, both sibs were shown to inherit the same maternal allele from the llpl3 region but different maternal alleles from the lIplS region. Using a combination of single-strand conformation polymorphism (SSCP) and polymerase chain reaction (PCR) sequencing techniques, no mutations were identified in the WTI tumour-suppressor gene from the 1lp13 region, but a novel polymorphism was identified in exon 1. mRNA expression studies using the insulin-like growth factor II (IGF-II) gene, located in 11 p15, showed that there was no relaxation of imprinting at this locus. There was also no evidence of loss of heterozygosity on the long arm of chromosome 16. These findings indicate that the WTI and IGF-II genes, together with the long arm of chromosome 16, are not directly implicated in tumorigenesis in this Wilms family, but that a recombination event has occurred on the short arm of chromosome 11.
Patients with Wilms tumour (WT) and the so-called 'AGR triad' (aniridia, genitourinary abnormalities and mental retardation) invariably carry constitutional deletions involving the lipl3 region (Francke et al., 1979; Riccardi et al., 1978 Riccardi et al., , 1980 . Studies of polymorphic loci along the length of the short arm of chromosome 11 have revealed that loss of heterozygosity (LOH) from I lp also occurs in up to 30% of sporadic WTs (Fearon et al., 1984; Koufos et al., 1984; Orkin et al., 1984; Mannens et al., 1988; Wadey et al., 1990) . In some cases, however, LOH is found only in region 11 p15 and not in lipl3 (Mannens et al., 1988 (Mannens et al., , 1990 Reeve et al., 1989; Wadey et al., 1990) . These findings support the idea that genes in both the p13 and p15 regions of chromosome 11 are important in Wilms tumorigenesis.
Analysis of a number of deletions from WAGR patients defined the critical region of lp1 3, which led to the isolation of a candidate gene from this region (Call et al., 1990; Gessler et al., 1990) , known as WTI (Haber et al., 1990) . WTI consists of 10 exons, the last four of which each codes individually for a zinc finger (Haber et al., 1990) . The demonstration of a number of intragenic WTI deletions in tumour cells has provided evidence for a direct role for WTI in tumorigenesis (Haber et al., 1990; Cowell et al., 1991; Huff et al., 1991; Ton et al., 1991; Brown et al., 1992) . Recently, more precise analysis has led to identification of more subtle changes in WTI, including point mutations Baird et al., 1992a,b; Coppes et al., 1992; Little et al., 1992) and insertions (Baird et al., 1992a; Santos et al., 1993) from patients with both WAGR syndrome and sporadic unilateral and bilateral WT. This gene is therefore implicated directly in Wilms tumorigenesis, at least in some patients.
Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome that is also associated with tumour predisposition, but only 6% of patients develop WTs (Beckwith, 1963; Wiedemann, 1964) . Genetic analysis of BWS families has demonstrated linkage to markers on the short arm of chromosome 11 (Koufos et al., 1989; Ping et al., 1989) . This observation indicates the location of the BWS gene, which might also be involved in Wilms tumorigenesis, as suggested by LOH studies. Cytogenetic changes involving the Ilpl5 region (Waziri et al., 1983; Turleau et al., 1984) in a few BWS patients provides supportive evidence, although a specific candidate gene has not yet been identified.
LOH is generally considered to be a mechanism that 'exposes' recessive mutations in tumour-suppressor genes (Cavenee et al., 1983) . Recent LOH analysis of various chromosomal loci, other than llp, has demonstrated allele loss from the long arm of chromosome 16 in up to 20% of sporadic WTs (Maw et al., 1992) . Because these changes also occur in tumours showing LOH for llp, it has been suggested they are related to progression rather than initiation.
Examples of pedigrees segregating a predisposition to Wilms tumorigenesis are quite rare, with estimates of fewer than 1% of all reported patients having affected sibs or parents. Linkage analysis in four families with apparently dominant inheritance of WT, but with varying penetrance, has excluded the short arm of chromosome 11 (Grundy et al., 1988; Huff et al., 1988; Schwartz et al., 1991) and 16q (Huff et al., 1992) as the site of the hereditary predisposition gene in these patients. Clearly, the molecular pathogenesis of familial WT varies, and characterisation of other WT families is needed. We report here the analysis of a British WT family using markers from the short arm of chromosome 11 and the long arm of chromosome 16.
Family history
The family (family M) reported here represents the only two-generation family with Wilms tumour amongst the 983 cases currently notified to the UKCCSG Wilms tumour trials since their inception in 1979 (see Figure 1 for pedigree).
The mother (GOS 570) had a unilateral renal tumour diagnosed at the age of 6 months, which was resected: she received post-operative flank irradiation but no chemotherapy. She is now aged 25 years and remains healthy. Each of her children (GOS 250 and GOS 416) from freshly isolated lymphocytes and used to make constitutional DNA. The constitutional karyotype of family members was determined by standard methods of G-banding from peripheral blood lymphocytes.
Genomic DNA isolation High molecular weight DNA from tumour samples was prepared by grinding tissue to a fine powder in liquid nitrogen and resuspending it in approximately 20 ml of lysis buffer (50 mM sodium chloride, 10 mM EDTA, 150 mM Tris, 0.5% SDS). Proteolysis was achieved using 50 mg ml-' proteinase K for 16-24 h at 37°C. DNA was extracted using standard phenol-chloroform procedures (Sambrook et al., 1989) . EBV-transformed lymphoblastoid cell lines were resuspended in lysis buffer and DNA extracted in the same way.
RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR) Total cellular RNA was isolated from tumour samples using the acid guanidinium thiocyanate-phenol-chloroform method described by Chomczynski and Sacchi (1988) . RT-PCR was essentially as described by Baird et al. (1992a) , except that 30 instead of 40 cycles of PCR amplification were carried out.
DNA analysis LOH analysis of polymorphic markers from chromosome 11 was performed as previously described (Wadey et al., 1990) . Genomic DNA was amplified using a Techne PHC-2 thermocycler. The PCR, single-strand conformation polymorphism (SSCP) and direct sequencing procedures were essentially as described by Hogg et al. (1992) , using a series of oligonucleotide primers described previously (Baird et al., 1992a) . The WTJ oligonucleotide primers used widely in this study are those which amplify the 3' end of exon 1 of the gene and are designated: WTCIA 5'-TTCACTGTCCACTTTTCCGGCCAGT-3' WT3 x 1 5'-TAGGGGCGCTCCCCGGCCTA-3' WTC1A is a 25mer sense primer, starting at nucleotide position 274 of the sequence described by Haber et al. (1991) , whereas WT3 x 1 is a 20mer antisense biotinylated primer, starting 26 bp 3' to the end of exon 1. Additional primer pairs used for LOH analysis were derived for D16S289 for chromosome region 16q22.2-q23.1 and D16S305 for chromosome region 16q24.2-q24.3 (Thomson et at., 1992). These two sets of primers were used to amplify CA repeats. All primers were synthesised on phosphoramide columns (ICRF Central Services Division). Amplified products, except CA repeats, were electrophoresed on 2% agarose gels. In the case of CA repeats, SSCP-PCR reactions involving 30 cycles of PCR were performed as described by Hogg et al. (1992) and the products electrophoresed on 6% polyacrylamide-urea gels.
Expression studies Primers P2 and P3, previously described by Ogawa et al. (1993) , were used to amplify part of the 3' untranslated region of the IGF-II gene using PCR (Ogawa et al., 1993; Rainer et al., 1993) and conditions of 50°C for 30 s, 72°C for 30 s and 96°C for 30s for 30 cycles from first-strand synthesised cDNA (Baird et al., 1992a) . Subsequent ApaI digestion of the resulting 292 bp PCR product allowed identification of both alleles associated with this polymorphism (Tadokaro et al., 1992) . RNA preparations were treated with RNAse-free DNAse prior to PCR amplification.
Results
Cytogenetic analysis of constitutional cells from all four family members showed normal karyotypes. Therefore PCR was used to analyse constitutional DNA from all three affected members as well as tumour tissue (GOS 249 and GOS 399 respectively) from both GOS 250 and GOS 416.
Initially the polymorphic HindIII site within the P-globin gene (HBG) locus, which lies in lp1 5, was studied. If this site was present, the 328 bp fragment generated by the primers A 11/A12 (Baird et al., 1992a) was digested, resulting in two bands 91 bp and 237 bp long (Figure 2 ). The affected mother (GOS 570) was heterozygous at this locus. The unaffected father (GOS 571) and his son (GOS 250) were homozygous for the 328 bp band, but the daughter (GOS 416) was heterozygous (Figure 2 ). This observation indicated that the two children had inherited different copies of chromosome 11 from their mother. Analysis of the HRAS locus, which is located more distally in llpl5, using the EcoRI polymorphism (Feinberg & Vogelstein, 1983) , confirmed that both sibs had inherited different alleles from their mother (Figure 3) Analysis of the catalase (CAT) locus, however, which lies proximal to the WTI gene in lp1 3, showed that both children had inherited the same allele from their mother (Figure 3 ). Clearly, a recombination event had occurred between the p13 and p15 region on the short arm of chromosome 11. Using a number of other lip probes the recombination event was shown to have occurred between the CAT and FSHB loci in lpl3 (Figure 3) (Wadey et al., 1990) and experiments with the WT33 cDNA probe (Call et al., 1990) showed no gross structural rearrangements in the WTI gene (Cowell et al., 1991) . Analysis of known polymorphisms in exon 7 (Groves et al., 1992) patients was therefore carried out as described previously (Baird et al., 1992a; Cowell et al., 1993) . Despite complete sequencing of the zinc finger region, no mutations were detected. During SSCP analysis of the remaining six exons of WTI in family M, an abnormal banding pattern was seen in exon 1. PCR sequence analysis revealed that the band migration shift detected on the SSCP gel in this exon was due to a sequence change resulting from a C-*T transition (Figure 4 ) at position 390 according to the sequence described by Haber et al. (1991) . All three affected members of the family were heterozygous at this position, whereas the unaffected father (GOS 571) was homozygous for the C nucleotide (Figure 4 ). This polymorphism occurs in the triplet sequence AAC, which codes for asparagine, located at codon 130 in WTI, and does not lead to any alteration of the amino acid sequence. Coincidentally, this transition affects the recognition site (CGCG) of the restriction enzyme AccII, which provides a convenient way of identifying this polymorphism. The PCR product generated from the primer combination WTlA/3XlB (Baird et al., 1992a digested by AccII in T/T homozygotes ( Figure 5 ). If the C nucleotide is present, however, AccII digestion generates two bands, 128 bp and 76 bp long ( Figure 5 ). Analysis of family M using the AccII restriction enzyme demonstrates that both children have inherited the same allele from their affected mother ( Figure 5 ). Analysis of this polymorphism using mRNA extracted from both blood and tumour samples indicated that there was equal expression of both alleles (data not shown).
Because of the suggestion that imprinting (see Discussion) of the IGF-II gene at lp 15 is relaxed in some WTs (Ogawa et al., 1993; Rainer et al., 1993) , we studied this locus in family M. As both children in family M had inherited the same maternal lip13 allele, but different maternal alleles at 1lpl5, we wanted to assess whether imprinting was a factor in tumorigenesis in this family. A polymorphism in the 3' untranslated region of the IGF-II gene was used to assess mRNA expression. PCR products using the primers P2 and P3 (Ogawa et al., 1993; Rainer et al., 1993) were used to amplify a 292 bp product (Figure 6 ). The polymorphism present in this fragment produces an ApaI enzyme digestion site. Digestion with this enzyme produces two smaller fragments, 231 bp and 61 bp long (Figure 6 ). Initially DNA was amplified and digested to show that all family members were heterozygous at this site (data not shown). In the mRNA analysis, amplification might also result from con-292 bp--> taminating DNA. This potential problem was overcome by pretreating the mRNA sample used for strand cDNA synthesis with RNAse-free DNAse and checking that no PCR products were produced (Figure 6 ). RNA expression in both probands, as well as two controls, indicated that the 292 bp allele was not expressed, whereas the allele with the ApaI site was expressed in all cases (Figure 6 ).
LOH studies have indicated the site of a third possible WT locus on the long arm of chromosome 16 (Maw et al., 1992) . To assess LOH of this chromosomal region of family M, two CA repeats from the D16S289 (16q22-q23.l) and D16S305 (16q24.2-q24.3) loci were studied. Each parent (GOS 570 and GOS 571) had a unique number of CA repeats, distinguishable on polyacrylamide-urea gels, and analysis of the probands (GOS 250 and GOS 416) indicated normal Mendelian inheritance at these loci with no evidence for LOH (data not shown).
Discussion
Fewer than 1% of all WT patients have a prior family history of tumours (Beckwith, 1983; Bonaiti-Pellie et al., 1992) , and complete penetrance of WT, indicating autosomal dominant inheritance, is unique. Mathematical consideration of the age, incidence and frequency of bilateral tumours in sporadic Wilms patients provided strong evidence for a genetic basis for WT predisposition in some patients (Knudson & Strong, 1972) . However, in previous studies of familial WT involving only three kindreds no linkage to chromosome 11 markers was demonstrated and no evidence of a mutation in WTI was found (Grundy et al., 1988; Huff et al., 1988; Schwartz et al., 1991) . In this study, although the family was small, penetrance was complete, all tumours arose within the first 8 months of life and each affected member had exactly the same histological tumour subtype. Taken together, these observations indicate that the disease phenotype is probably due to an autosomal dominant mutation segregating in this family which predisposes to tumorigenesis. Co-segregation of markers from llpl3 with the tumour phenotype was observed, but a recombination event between WTI and HRAS demonstrates that the predisposition gene does not lie in the llpl5 region in this family. Analysis of the AccII polymorphism in exon 1 of WTI showed that both children had inherited the same WTI gene from their affected mother. It was possible, therefore, that a mutation in WTI was responsible for tumour predisposition. However, tumour DNA samples were heterozygous at the WTI locus. There have been reports of heterozygous mutations in WTI with no associated loss of heterozygosity (Haber et al., 1990; Little et al., 1992) malities, except for that responsible for the AccII polymorphism. In light of our past experience with SSCP/sequencing (Baird et al., 1992b; Cowell et al., 1993) , as well as that of others (Coppes et al., 1993) , we feel certain that mutations are unlikely to be present within exons 1-6 of the coding region of the WTI gene from the members of family M, although we do accept that this technology may not be able to detect all mutations. In addition, mRNA expression studies, based on the AccII polymorphism, indicated that both alleles were equally expressed in patients GOS 250 and GOS 416, thereby arguing against a mutation in the promoter region of WTI. A number of studies, however, have indicated that uniparental disomy for region llpl5 occurs in patients with BWS and may be associated with the increased incidence of WT observed in these patients (Henry et al., 1991) . Our analysis of the Ip 1 5 region in family M, based on the ApaI polymorphism in the IGF-II gene, indicated that the affected probands were heterozygous, which excludes uniparental disomy as a mechanism of tumorigenesis in this family. Two loci (IGF-II and H19) in the 1 lplS region are syntenic to loci on mouse chromosome 7, and it has been shown that the H19 locus is paternally imprinted (Bartolomei et al., 1991) , whereas the IGF-II locus is maternally imprinted (DeChiara et al., 1991) . Two recent reports indicate that both the H19 and IGF-II genes are also imprinted in normal human tissues but that this imprinting is relaxed in WT (Ogawa et al., 1993; Rainer et al., 1993) . The ApaI polymorphism in the IGF-II gene provides a convenient way of assessing which allele is expressed in WT. In the tumours of the two probands of family M there was no evidence for relaxation of imprinting at this locus, as only one allele was expressed. It was not possible to assess the parental origin of this allele as both parents were heterozygous at this locus.
On the basis of relatively frequent LOH, it has been suggested that a potential third WT locus lies within chromosome region 16q22.1-16qter (Maw et al., 1992) . Using two CA repeats, D16S289 and D16S305, located in 16q22.2-q23.1 and 16q24.2-q24.3 respectively, no LOH was detected in either of the tumours from the probands in family M, indicating that these regions of chromosome 16 are unlikely to contain a tumour-suppressor gene involved in familial WT. This was also the conclusion of a recent linkage analysis using five WT families (Huff et al., 1992) .
In summary, all three tumours from family M had the same monomorphous, epithelial-type WT, and all presented at <1 year of age. This histological variant of WT accounts for fewer than 5% of all Wilms tumours, so the chance of this happening by coincidence within this family is less than 1:105. A specific genetic event, so far not defined, appears to have been transmitted through the affected family members which is causative of this particular histopathological change but its chromosomal location is, as yet, unknown. Because of the complete penetrance of the tumour phenotype this family will clearly be important for the future characterisation of candidate WT genes.
